Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Overview

Feature Articles

Latest Diabetes News and Research

Family support helped adults in rural China to reduce blood pressure levels

Family support helped adults in rural China to reduce blood pressure levels

Ultra-processed foods linked to precursors of early-onset colorectal cancer

Ultra-processed foods linked to precursors of early-onset colorectal cancer

Funding challenges threaten to reverse global gains in the fight against TB

Funding challenges threaten to reverse global gains in the fight against TB

New approach to kidney transplant listing could improve outcomes and equity

New approach to kidney transplant listing could improve outcomes and equity

Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH

Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH

Which plant-based diet is healthiest and most sustainable

Which plant-based diet is healthiest and most sustainable

Income and social disparities found to influence dementia risk factors

Income and social disparities found to influence dementia risk factors

Potential breakthrough in treating acute kidney injury with ceramide-targeting drugs

Potential breakthrough in treating acute kidney injury with ceramide-targeting drugs

Study clarifies how biliary atresia overlaps with multiple congenital syndromes

Study clarifies how biliary atresia overlaps with multiple congenital syndromes

What the air you breathe may be doing to your brain

What the air you breathe may be doing to your brain

What diet do people with type 2 diabetes really want? Study reveals flexibility beats strict meal plans

What diet do people with type 2 diabetes really want? Study reveals flexibility beats strict meal plans

Evolocumab shows clear benefit in preventing first-time heart attacks and strokes

Evolocumab shows clear benefit in preventing first-time heart attacks and strokes

Financial incentives increase medication adherence but do not improve blood pressure outcomes

Financial incentives increase medication adherence but do not improve blood pressure outcomes

Blue Zones and ACLM launch certification empowering clinicians to promote longevity and well-being

Blue Zones and ACLM launch certification empowering clinicians to promote longevity and well-being

Midlife blood test may reveal Alzheimer’s disease risk in advance

Midlife blood test may reveal Alzheimer’s disease risk in advance

Mapping London’s food deserts and nutrition gaps

Mapping London’s food deserts and nutrition gaps

Study examines medication adherence in high-risk, low-income populations

Study examines medication adherence in high-risk, low-income populations

Metformin shows promise in treating AFib recurrence after ablation

Metformin shows promise in treating AFib recurrence after ablation

Anticoagulants increase bleeding post-ablation with no added stroke benefit

Anticoagulants increase bleeding post-ablation with no added stroke benefit

New data supports earlier use of evolocumab in high-risk diabetes

New data supports earlier use of evolocumab in high-risk diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.